CanariaBio Completes Enrollment For Oregovomab Phase 2 In Ovarian Cancer
23 Aug 2024 //
PR NEWSWIRE
CanariaBio and Hikma announce the signing of agreement for oregovomab
10 Oct 2023 //
PR NEWSWIRE
23 Aug 2024 //
PR NEWSWIRE
10 Oct 2023 //
PR NEWSWIRE